The vial size determines how much bacteriostatic water you add, which determines the concentration of your final solution, which determines how many units you draw for each dose
Very few to no side effects have been reported so far with those under practitioner care with BPC 157
PF-06952229, an inhibitor of TGF-R1, is being evaluated in a phase I dose-escalation study for its safety, tolerability, and pharmacokinetics in patients with advanced solid tumors (NCT03685591)
For the scenario of "Gut and GI Protection," research data suggests BPC-157 may be more relevant
For eczema patients with concurrent gut inflammation, BPC-157 may address both conditions simultaneously
These ingredients work together to support fat breakdown, energy production, appetite control, mood enhancement, stress management, and liver cleansing [1]